Kevin M. Lawrence

2.1k total citations
47 papers, 1.6k citations indexed

About

Kevin M. Lawrence is a scholar working on Molecular Biology, Behavioral Neuroscience and Pharmacology. According to data from OpenAlex, Kevin M. Lawrence has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Behavioral Neuroscience and 15 papers in Pharmacology. Recurrent topics in Kevin M. Lawrence's work include Stress Responses and Cortisol (18 papers), Treatment of Major Depression (12 papers) and Adipose Tissue and Metabolism (11 papers). Kevin M. Lawrence is often cited by papers focused on Stress Responses and Cortisol (18 papers), Treatment of Major Depression (12 papers) and Adipose Tissue and Metabolism (11 papers). Kevin M. Lawrence collaborates with scholars based in United Kingdom, United States and Australia. Kevin M. Lawrence's co-authors include David S. Latchman, Anastasis Stephanou, Paul A. Townsend, Richard A. Knight, Roger W. Horton, Tiziano M. Scarabelli, Cornelius Katona, Linda Petrie, Henry Asare‐Anane and Peter M. Jones and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Kevin M. Lawrence

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin M. Lawrence United Kingdom 23 601 414 378 257 252 47 1.6k
Barbara Lubec Austria 27 444 0.7× 406 1.0× 75 0.2× 216 0.8× 506 2.0× 70 1.8k
Monica Ek Sweden 18 515 0.9× 321 0.8× 197 0.5× 240 0.9× 51 0.2× 21 2.0k
Susanna M.O. Hourani United Kingdom 26 678 1.1× 373 0.9× 107 0.3× 483 1.9× 101 0.4× 56 2.0k
Jie Cai China 29 541 0.9× 1.1k 2.8× 122 0.3× 598 2.3× 91 0.4× 60 2.8k
George N. Chaldakov Bulgaria 28 508 0.8× 524 1.3× 60 0.2× 584 2.3× 186 0.7× 121 2.2k
Ralph Plehm Germany 24 685 1.1× 295 0.7× 122 0.3× 238 0.9× 108 0.4× 37 2.6k
Alex J. Baertschi United States 27 505 0.8× 332 0.8× 359 0.9× 312 1.2× 87 0.3× 85 1.9k
Daniela Carnevale Italy 31 722 1.2× 473 1.1× 114 0.3× 225 0.9× 78 0.3× 67 2.4k
Lorena Arranz Spain 23 539 0.9× 296 0.7× 281 0.7× 146 0.6× 55 0.2× 39 2.1k
Rodney M. Ritzel United States 34 1.1k 1.8× 365 0.9× 71 0.2× 327 1.3× 257 1.0× 59 3.6k

Countries citing papers authored by Kevin M. Lawrence

Since Specialization
Citations

This map shows the geographic impact of Kevin M. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Lawrence more than expected).

Fields of papers citing papers by Kevin M. Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Lawrence. The network helps show where Kevin M. Lawrence may publish in the future.

Co-authorship network of co-authors of Kevin M. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Lawrence. A scholar is included among the top collaborators of Kevin M. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Lawrence. Kevin M. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, R.C., et al.. (2018). Piezo1 expression is increased in response to non-invasive impact of mouse knee joint. Osteoarthritis and Cartilage. 26. S113–S114. 3 indexed citations
2.
Owens, G, Kevin M. Lawrence, Emma J. Crosbie, et al.. (2017). Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen. Cancer Medicine. 6(2). 408–415. 12 indexed citations
3.
Lawrence, Kevin M., R.C. Jones, Thomas Jackson, et al.. (2017). Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1. Scientific Reports. 7(1). 5147–5147. 43 indexed citations
4.
Fuller, K., Anthony P. Albert, Grisha Pirianov, et al.. (2011). Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel. Journal of Endocrinology. 212(2). 187–197. 12 indexed citations
5.
Crompton, Douglas E., Ingrid E. Scheffer, I Taylor, et al.. (2010). Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain. 133(11). 3221–3231. 60 indexed citations
6.
Fuller, K., Kevin M. Lawrence, Urszula Grabowska, et al.. (2007). Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. Bone. 42(1). 200–211. 98 indexed citations
7.
Lawrence, Kevin M. & D Latchman. (2006). The Urocortins: Mechanisms of Cardioprotection and Therapeutic Potential. Mini-Reviews in Medicinal Chemistry. 6(10). 1119–1126. 15 indexed citations
8.
Knight, R.K., Anastasis Stephanou, Paul A. Townsend, et al.. (2006). Clinical Implications of Apoptosis in Ischemic Myocardium. Current Problems in Cardiology. 31(3). 181–264. 65 indexed citations
9.
Collino, Massimo, Nimesh S. A. Patel, Kevin M. Lawrence, et al.. (2005). The selective PPARγ antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney International. 68(2). 529–536. 48 indexed citations
10.
Townsend, Paul A., Ramsey Cutress, Christopher J. Carroll, et al.. (2004). BAG-1 Proteins Protect Cardiac Myocytes from Simulated Ischemia/Reperfusion-induced Apoptosis via an Alternate Mechanism of Cell Survival Independent of the Proteasome. Journal of Biological Chemistry. 279(20). 20723–20728. 47 indexed citations
11.
Scarabelli, Tiziano M., Evasio Pasini, Mario Ferrari, et al.. (2004). Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells. Journal of Thoracic and Cardiovascular Surgery. 128(3). 364–371. 26 indexed citations
12.
Scarabelli, Tiziano M., Anastasis Stephanou, Evasio Pasini, et al.. (2004). Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. Journal of the American College of Cardiology. 43(5). 865–874. 114 indexed citations
13.
Lawrence, Kevin M., Paul A. Townsend, Sean M. Davidson, et al.. (2004). The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage. Biochemical and Biophysical Research Communications. 321(2). 479–486. 25 indexed citations
14.
Brar, Bhawanjit K., Anastasis Stephanou, Kevin M. Lawrence, et al.. (1999). CRH-like peptides protect cardiac myocytes from lethal ischaemic injury. Molecular and Cellular Endocrinology. 158(1-2). 55–63. 99 indexed citations
15.
Lawrence, Kevin M., et al.. (1997). Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients. Journal of Affective Disorders. 46(2). 127–134. 4 indexed citations
16.
Healy, David, Andrew M. Whitehouse, William J. White, et al.. (1991). Alpha-1-acid glycoprotein in major depressive and eating disorders. Journal of Affective Disorders. 22(1-2). 13–20. 47 indexed citations
17.
Theodorou, Andreas E., Kevin M. Lawrence, David Healy, et al.. (1991). Platelet α2-adrenoceptors, defined with agonist and antagonist ligands, in depressed patients, prior to and following treatment. Journal of Affective Disorders. 23(3). 99–106. 8 indexed citations
18.
Healy, David, Andreas E. Theodorou, Andrew M. Whitehouse, et al.. (1990). 3H-Imipramine Binding to Previously Frozen Platelet Membranes from Depressed Patients, Before and After Treatment. The British Journal of Psychiatry. 157(2). 208–215. 21 indexed citations
19.
Lawrence, Kevin M., Freddy De Paermentier, Sharon C. Cheetham, et al.. (1990). Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Research. 526(1). 17–22. 71 indexed citations
20.
Koshikawa, Noriaki, et al.. (1987). Subcellular distribution of β-adrenoceptors in brain following administration of antidepressant drugs. Neuropharmacology. 26(9). 1343–1349. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026